|
|
New MRSA Treatment Guidelines May Encourage Nephrotoxic Vancomycin Doses
|
| Link ID |
6127 |
| Title |
New MRSA Treatment Guidelines May Encourage Nephrotoxic Vancomycin Doses |
| Url |
http://www.medscape.com/viewarticle/575036?src=rss |
| Description |
Recent guidelines recommending vancomycin trough concentrations of 15-20 mg/L for patients with methicillin-resistant Staphylococcus aureus (MRSA) infections may prompt the use of vancomycin doses of 4 mg a day or greater -- doses that are associated with nephrotoxicity, investigators warn in the April issue of Antimicrobial Agents and Chemotherapy. Reuters Health Information |
| Category |
Articles > Critical Care |
| Keywords |
|
| Date |
May 29, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Critical Care |
|
|